APA (7th ed.) Citation

Curone, M., Tullo, V., Didier, H. A., & Bussone, G. (2022). Overview on effectiveness of erenumab, fremanezumab, and galcanezumab in reducing medication overuse headache in chronic migraine patients. Neurological Sciences, 43(9), 5759. https://doi.org/10.1007/s10072-022-06265-8

Chicago Style (17th ed.) Citation

Curone, Marcella, Vincenzo Tullo, Henri Albert Didier, and Gennaro Bussone. "Overview on Effectiveness of Erenumab, Fremanezumab, and Galcanezumab in Reducing Medication Overuse Headache in Chronic Migraine Patients." Neurological Sciences 43, no. 9 (2022): 5759. https://doi.org/10.1007/s10072-022-06265-8.

MLA (9th ed.) Citation

Curone, Marcella, et al. "Overview on Effectiveness of Erenumab, Fremanezumab, and Galcanezumab in Reducing Medication Overuse Headache in Chronic Migraine Patients." Neurological Sciences, vol. 43, no. 9, 2022, p. 5759, https://doi.org/10.1007/s10072-022-06265-8.